Anika Therapeutics, Inc. (ANIK) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.87 --0%
Financial Fact:
Cost of product revenue: 5M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Financial Fact:
Cost of product revenue: 5M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q1 EPS of $0.14, $0.03 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $14.4 million versus the consensus estimate of $18.2 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Goldman Sachs sees refinery exemptions boosting DK cash flow
- UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
